Innoviva (INVA) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 17.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.12% |
| Sep 30, 2025 | -13.81% |
| Jun 30, 2025 | 21.51% |
| Mar 31, 2025 | 31.05% |
| Sep 30, 2024 | 43.54% |
| Jun 30, 2024 | 51.77% |
| Mar 31, 2024 | 47.76% |
| Sep 30, 2023 | 48.43% |
| Jun 30, 2023 | 59.44% |
| Mar 31, 2023 | 54.30% |
| Sep 30, 2022 | 96.62% |
| Jun 30, 2022 | 41.75% |
| Mar 31, 2022 | 16.39% |
| Sep 30, 2021 | 67.63% |
| Jun 30, 2021 | 37.29% |
| Mar 31, 2021 | -40.76% |
| Dec 31, 2020 | -43.10% |
| Sep 30, 2020 | -43.71% |
| Jun 30, 2020 | -46.34% |
| Mar 31, 2020 | -44.22% |
| Dec 31, 2019 | -36.14% |
| Sep 30, 2019 | -34.22% |
| Jun 30, 2019 | -44.95% |
| Mar 31, 2019 | -31.28% |
| Dec 31, 2018 | -33.46% |
| Sep 30, 2018 | -28.79% |
| Jun 30, 2018 | -34.61% |
| Mar 31, 2018 | 3.91% |
| Dec 31, 2017 | 20.79% |
| Sep 30, 2017 | -19.46% |
| Jun 30, 2017 | -32.08% |
| Mar 31, 2017 | -43.00% |
| Dec 31, 2016 | -32.09% |
| Sep 30, 2016 | -35.65% |
| Jun 30, 2016 | -26.52% |
| Mar 31, 2016 | -32.63% |
| Dec 31, 2015 | -34.00% |
| Sep 30, 2015 | -36.85% |
| Jun 30, 2015 | -32.71% |
| Mar 31, 2015 | -32.32% |
| Dec 31, 2014 | -39.47% |
| Sep 30, 2014 | -11.77% |
| Jun 30, 2014 | 7.28% |
| Mar 31, 2014 | 34.68% |
| Dec 31, 2013 | 8.43% |
| Sep 30, 2013 | 12.76% |